BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1666 related articles for article (PubMed ID: 8581388)

  • 1. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    J Hematother; 1995 Oct; 4(5):477-83. PubMed ID: 8581388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
    Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
    Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron neutron capture therapy of primary and metastatic brain tumors.
    Barth RF; Soloway AH
    Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy.
    Barth RF; Adams DM; Soloway AH; Alam F; Darby MV
    Bioconjug Chem; 1994; 5(1):58-66. PubMed ID: 8199235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
    Barth RF; Soloway AH; Brugger RM
    Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
    Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
    Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron neutron capture therapy of cancer: current status and future prospects.
    Barth RF; Coderre JA; Vicente MG; Blue TE
    Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy for cancer. Realities and prospects.
    Barth RF; Soloway AH; Fairchild RG; Brugger RM
    Cancer; 1992 Dec; 70(12):2995-3007. PubMed ID: 1451084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
    Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
    Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors.
    Capala J; Barth RF; Bendayan M; Lauzon M; Adams DM; Soloway AH; Fenstermaker RA; Carlsson J
    Bioconjug Chem; 1996; 7(1):7-15. PubMed ID: 8741985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy for glioblastoma.
    Yamamoto T; Nakai K; Matsumura A
    Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for boronating antibodies without loss of immunoreactivity, for use in neutron capture therapy.
    Ferro VA; Morris JH; Stimson WH
    Drug Des Discov; 1995 Aug; 13(1):13-25. PubMed ID: 8882898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
    Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
    Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
    Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
    Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The basis and advances in clinical application of boron neutron capture therapy.
    He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
    Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal neutron capture therapy of malignant melanoma using 10B-monoclonal antibodies: in vitro and in vivo analysis.
    Komura A; Nakagawa T; Ichihashi M; Mishima Y
    Melanoma Res; 1992; 1(5-6):397-403. PubMed ID: 1422196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy.
    Wu G; Barth RF; Yang W; Chatterjee M; Tjarks W; Ciesielski MJ; Fenstermaker RA
    Bioconjug Chem; 2004; 15(1):185-94. PubMed ID: 14733599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.